GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver
Status:
Completed
Trial end date:
2018-10-31
Target enrollment:
Participant gender:
Summary
The primary objective is to determine the galactose single point (GSP) cutoff values to
discriminate subjects with different hepatic function. The secondary objective is to analyze
the correlations between GSP and other hepatic function assessment methods among this trial
subjects.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Defense Medical Center, Taiwan
Collaborators:
Cardinal Tien Hospital Tri-Service General Hospital